+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Kyphoplasty and Percutaneous Discectomy - Global Strategic Business Report

  • PDF Icon

    Report

  • 368 Pages
  • October 2026
  • Region: Global
  • Market Glass, Inc.
  • ID: 6098738
The global market for Kyphoplasty and Percutaneous Discectomy was valued at US$2.3 Billion in 2025 and is projected to reach US$3.0 Billion by 2032, growing at a CAGR of 4.3% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Kyphoplasty and Percutaneous Discectomy Market - Key Trends & Drivers Summarized

Why Are Minimally Invasive Spinal Procedures Like Kyphoplasty and Discectomy Gaining Prominence?

Kyphoplasty and percutaneous discectomy have become crucial tools in the management of spinal disorders, offering minimally invasive alternatives to traditional open surgeries. Kyphoplasty is used to treat vertebral compression fractures, typically caused by osteoporosis or trauma, by restoring vertebral height and stabilizing the spine using bone cement. Percutaneous discectomy, on the other hand, is employed to relieve pressure from herniated or bulging discs that compress spinal nerves, causing pain and limited mobility. Both procedures enable faster recovery, lower complication rates, and shorter hospital stays - key advantages that are driving their rising adoption globally.

As the burden of degenerative spine diseases, trauma-related fractures, and age-related spinal deformities increases, healthcare providers are shifting toward procedures that minimize disruption to surrounding tissues and reduce post-operative care needs. This demand is especially high in elderly and comorbid patient populations, where traditional spine surgery often presents high risk. With a growing emphasis on cost-effective care, these minimally invasive procedures are now seen as frontline interventions for spinal pain management and fracture correction.

How Are Technological Innovations Transforming Procedural Outcomes and Access?

Ongoing advancements in spinal navigation systems, intraoperative imaging, and orthopedic biomaterials are significantly improving the accuracy and safety of kyphoplasty and percutaneous discectomy. The use of fluoroscopy, 3D CT, and real-time MRI guidance enables clinicians to target pathological sites with high precision while avoiding damage to surrounding structures. This is especially important in anatomically complex regions like the thoracic spine, where accurate access is critical to procedural success.

In kyphoplasty, innovations in bone cement formulations - including bioactive, radiopaque, and low-viscosity variants - are enhancing vertebral stabilization and reducing leakage risks. Meanwhile, percutaneous discectomy procedures are benefitting from improvements in minimally invasive access tools such as endoscopes, radiofrequency ablation probes, and laser-assisted systems. Some newer systems also combine mechanical decompression with thermal or chemical ablation, enhancing the efficacy of nucleus removal while minimizing thermal injury. These technological enhancements are helping standardize outcomes and broaden the candidate pool for these procedures.

Which Demographics and Healthcare Systems Are Driving Utilization of These Techniques?

Elderly populations suffering from osteoporosis-induced vertebral compression fractures are the primary beneficiaries of kyphoplasty. The increasing global prevalence of age-related bone loss and spinal deformities makes this procedure especially relevant in high-income and aging societies such as Japan, Germany, and the United States. Similarly, percutaneous discectomy is widely used among working-age individuals and athletes dealing with lumbar disc herniations and radiculopathy, particularly in orthopedics and sports medicine settings.

North America leads the market due to a high volume of spinal procedures, favorable reimbursement structures, and widespread adoption of advanced imaging and surgical tools. Europe follows closely, supported by strong public healthcare systems and an emphasis on early mobility and outpatient care. Asia-Pacific, particularly China and India, is witnessing rapid growth as healthcare infrastructure expands, awareness of spinal health increases, and patient access to minimally invasive techniques improves. The Middle East and Latin America are emerging markets where private healthcare providers are beginning to adopt these solutions as demand for pain-relieving spinal care rises.

The Growth in the Kyphoplasty and Percutaneous Discectomy Market Is Driven by Several Factors

It is driven by the increasing incidence of vertebral fractures, spinal disc disorders, and degenerative spine conditions globally. The aging population, particularly in developed and middle-income countries, is creating sustained demand for low-risk, high-efficacy spinal interventions. Technological advances in spinal instrumentation, surgical guidance, and cement materials are making these procedures safer, faster, and more accessible - encouraging their adoption across both inpatient and outpatient settings.

Additionally, healthcare providers are prioritizing early intervention and fast recovery in spine care, which aligns well with the advantages of kyphoplasty and percutaneous discectomy. Growing preference for day-care surgeries, improved anesthesia techniques, and expanded clinical evidence supporting these procedures are reinforcing their role in treatment guidelines. Insurance coverage improvements, surgeon training programs, and the rising number of ambulatory surgical centers (ASCs) are also contributing to wider availability. As spinal conditions continue to impact productivity and quality of life across age groups, these minimally invasive procedures are poised for steady growth and technological evolution.

Report Scope

The report analyzes the Kyphoplasty and Percutaneous Discectomy market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:
  • Segments: Procedure (Kyphoplasty, Percutaneous Discectomy); Application (Vertebral Alignment Restoration, Spinal Fractures, Kyphosis, Other Applications); End-Use (Hospitals, Clinics, Ambulatory Surgical Center, Other End-Uses)
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Kyphoplasty segment, which is expected to reach US$1.9 Billion by 2032 with a CAGR of a 3.7%. The Percutaneous Discectomy segment is also set to grow at 5.6% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $614.0 Million in 2025, and China, forecasted to grow at an impressive 7.4% CAGR to reach $623.5 Million by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Kyphoplasty and Percutaneous Discectomy Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Kyphoplasty and Percutaneous Discectomy Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Kyphoplasty and Percutaneous Discectomy Market expected to evolve by 2032?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2032?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Becton, Dickinson and Company, Biopsybell (BPB Medica), DePuy Synthes (Johnson & Johnson), G21 S.r.l., Halma plc and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Kyphoplasty and Percutaneous Discectomy market report include:

  • Becton, Dickinson and Company
  • Biopsybell (BPB Medica)
  • DePuy Synthes (Johnson & Johnson)
  • G21 S.r.l.
  • Halma plc
  • Jiangsu Changmei Medtech Co., Ltd.
  • Joimax GmbH
  • Joline GmbH & Co. KG
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • NuVasive, Inc.
  • Seawon MediTech
  • Smith & Nephew plc
  • Spinal Elements, Inc.
  • Stryker Corporation
  • Taeyeon Medical Co., Ltd.
  • Waston Medical Appliance Co., Ltd.
  • Zimed Medical Co., Ltd.
  • Zimmer Biomet Holdings, Inc.

What Sets This Report Apart From Others?

  • Grounded in Domain Expert Perspectives: Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.
  • Captures Early Market Signals: Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.
  • Draws From a Broad, Validated Intelligence Base: Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.
  • Connects Signals With Strategic Market Direction: Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.
  • Provides In-Depth Company Intelligence: Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.
  • Market Share Is Examined Where It Matters: A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, the report extends market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • World Market Trajectories
  • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
  • Lab Automation for In-Vitro Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Sample Throughput Requirements in Clinical Labs Propel Demand for Lab Automation Systems
  • Growing Shortage of Skilled Lab Technicians Throws the Spotlight on Workflow Automation
  • Expansion of Personalized Medicine and Genomic Testing Drives Automation in IVD Pipelines
  • Integration of Liquid Handling Robots and Smart Plate Readers Enhances IVD Accuracy and Efficiency
  • Regulatory Pressures for Standardization and Reproducibility Strengthen Case for Automated Platforms
  • Automation of Pre-Analytical Processes Expands Operational Efficiency in High-Volume Labs
  • Emergence of Closed-Loop Systems with AI Analytics Spurs Fully Integrated IVD Workflows
  • Growth in Infectious Disease Testing Accelerates Deployment of Automated PCR and ELISA Systems
  • Adoption of Modular and Scalable Architectures Drives Flexibility in Lab Automation
  • Point-of-Care Diagnostics Expansion Spurs Miniaturized and Integrated Lab-on-Chip Platforms
  • Growing Focus on Data Integrity and Traceability Drives Adoption of Digitalized Lab Processes
  • Use of Robotics in Specimen Transport and Sorting Enhances Turnaround Time and Reliability
  • Partnerships Between Diagnostic OEMs and Automation Providers Accelerate Innovation Pipelines
  • Rise in CLIA-Waived Test Volumes Sustains Growth in Semi-Automated Platforms
  • COVID-19 Pandemic-Driven Demand for Mass Testing Throws Spotlight on Automated IVD Equipment
  • Integration of LIMS and Cloud Infrastructure Expands Analytical Capabilities and Remote Access
  • High Capital Costs and Workflow Customization Needs Pose Barriers to Full Automation Adoption
  • Expansion of Hospital and Diagnostic Chains in Emerging Markets Generates New Demand Centers
  • Increased Investments in Automation for Oncology and Chronic Disease Diagnostics Propel Market Maturity
  • AI-Powered Image Analysis and Result Interpretation Drive Next-Gen IVD Automation Ecosystems
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Lab Automation for In-Vitro Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2020 through 2032
  • Table 2: World Recent Past, Current & Future Analysis for Lab Automation for In-Vitro Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 3: World Historic Review for Lab Automation for In-Vitro Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 4: World 13-Year Perspective for Lab Automation for In-Vitro Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
  • Table 5: World Recent Past, Current & Future Analysis for Automated Plate Handler by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 6: World Historic Review for Automated Plate Handler by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 7: World 13-Year Perspective for Automated Plate Handler by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 8: World Recent Past, Current & Future Analysis for Automated Liquid Handler by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 9: World Historic Review for Automated Liquid Handler by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 10: World 13-Year Perspective for Automated Liquid Handler by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 11: World Recent Past, Current & Future Analysis for Robotic Arm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 12: World Historic Review for Robotic Arm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 13: World 13-Year Perspective for Robotic Arm by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 14: World Recent Past, Current & Future Analysis for Automated Storage & Retrieval System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 15: World Historic Review for Automated Storage & Retrieval System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 16: World 13-Year Perspective for Automated Storage & Retrieval System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 17: World Recent Past, Current & Future Analysis for Analyzer Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 18: World Historic Review for Analyzer Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 19: World 13-Year Perspective for Analyzer Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 20: World Recent Past, Current & Future Analysis for Academic End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 21: World Historic Review for Academic End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 22: World 13-Year Perspective for Academic End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 23: World Recent Past, Current & Future Analysis for Laboratory End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 24: World Historic Review for Laboratory End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 25: World 13-Year Perspective for Laboratory End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 26: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 27: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 28: World 13-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
III. MARKET ANALYSIS
UNITED STATES
  • Lab Automation for In-Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
CANADA
JAPAN
  • Lab Automation for In-Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
CHINA
  • Lab Automation for In-Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
EUROPE
  • Lab Automation for In-Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
FRANCE
  • Lab Automation for In-Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
GERMANY
  • Lab Automation for In-Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
ITALY
UNITED KINGDOM
  • Lab Automation for In-Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Lab Automation for In-Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
AUSTRALIA
  • Lab Automation for In-Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
INDIA
  • Lab Automation for In-Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Lab Automation for In-Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Lab Automation for In-Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Lab Automation for In-Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Becton, Dickinson and Company
  • Biopsybell (BPB Medica)
  • DePuy Synthes (Johnson & Johnson)
  • G21 S.r.l.
  • Halma plc
  • Jiangsu Changmei Medtech Co., Ltd.
  • Joimax GmbH
  • Joline GmbH & Co. KG
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • NuVasive, Inc.
  • Seawon MediTech
  • Smith & Nephew plc
  • Spinal Elements, Inc.
  • Stryker Corporation
  • Taeyeon Medical Co., Ltd.
  • Waston Medical Appliance Co., Ltd.
  • Zimed Medical Co., Ltd.
  • Zimmer Biomet Holdings, Inc.

Table Information